TNGX (Tango Therapeutics) Bozor qiymatining balans qiymatiga nisbati

Tango Therapeutics (TNGX) kompaniyasining rasmiy ramzlari

Tango Therapeutics genetik tahlillarni aniq dori vositalarini tanlash bilan birlashtirgan holda o'smalarga qarshi kurashish uchun keng qamrovli muhit yaratmoqda. Biznes hozirda faol moliyalashtirish bosqichida bo'lib, 3.78 ko'rsatkichi bilan qayd etilganidek, ishlanmalar xarajatlari daromadlardan sezilarli darajada yuqoridir. Jori narxlar dinamikasi kompaniyaning immunoterapiyani tubdan isloh qilish uchun AI platformalari va kichik molekulalarni joriy etayotgan innovator sifatidagi maqomini tasdiqlaydi.

Tango Therapeutics Corp (TNGX): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha
Tango Pharma brendining mahsuloti

Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlari bilan solishtirib, kapitalning balans qiymatiga nisbatan premium yoki diskontni aniqlaydi. Bozor va balans baholash ko'rsatkichlarining ushbu grafigi investorlarning Tango Therapeutics (TNGX) kompaniyasining sintetik letallik sohasidagi intellektual mulki qiymatiga va saratonning chidamli shakllarini davolash uchun mo'ljallangan maqsadli dori vositalari portfelining potensialiga bo'lgan kutganlarini aks ettiradi.

Raqobatchilar tahlili

Kapitallashuvning sof aktivlarga nisbati ImmunityBio, Inc.|IMCR (immunocore.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati JANX (Janux Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti RCUS|Bozor qiymatining balans qiymatiga nisbati Zymeworks Corp ZYME|Kapitallashuvning balans qiymatiga nisbati Iovance Corp (IOVA)|Immatics N.V. - Bozor kapitallashuvining balans qiymatiga nisbati|xencor.com - Kapitallashuvning sof aktivlarga nisbati|CMPX (Compass Therapeutics, Inc.) - Bozor qiymatining balans qiymatiga nisbati|REPL: Bozor qiymatining balans qiymatiga koeffitsiyenti|Lyell Immunopharma Inc (LYEL) - Bozor qiymatining balans qiymatiga nisbati|IPHA (Innate Pharma S.A) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati PYXS (Pyxis Oncology Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Compugen Limited|IOBT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Sutro Biopharma Inc. STRO|INKT: Kapitallashuvning sof aktivlarga nisbati|HOWL - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Immix (IMMX)|ALXO - Balans qiymatiga nisbatan bozor qiymati|Cue Biopharma - Bozor kapitallashuvining balans qiymatiga nisbati|PDSB (PDS Biotechnology Corporation) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati SONN|Kapitallashuvning sof aktivlarga nisbati MAIA|Bozor qiymatining balans qiymatiga nisbati LIMN (Liminatus Pharma)|Kapitallashuvning sof aktivlarga nisbati lavatherapeutics.com LVTX|Kapitallashuvning sof aktivlarga nisbati NXTC (NextCure)|Leap Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Intensity Tx (INTS) - Bozor qiymatining balans qiymatiga nisbati|SNSE: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati TOVX|Bozor qiymatining balans qiymatiga koeffitsiyenti Gritstone bio|Kineta - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining xususiy kapitalga nisbati NexImmune Inc (NEXI)|Kapitallashuvning sof aktivlarga nisbati Turnstone Biologics|Bozor kapitallashuvining balans qiymatiga multiplikatori Vaccinex Inc (VCNX)|Bozor kapitallashuvining balans qiymatiga nisbati Harpoon Therapeutics